Becker's Healthcare October 7, 2024
Alexandra Murphy

Novo Nordisk plans to invest approximately $158 million into revamping its Montes Claros manufacturing facility in Minas Gerais, Brazil, Bloomberg reported Oct. 5.

The plant is crucial for the company, producing 25% of its global insulin output. The modernization efforts aim to enhance production capabilities and incorporate sustainability projects that align with global environmental goals.

Since...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Investments, Pharma, Pharma / Biotech, Trends
GenAI and the revolution of drug development
Amgen starts two critical late-stage trials for weight loss drug MariTide
Patient Access To Cheaper Biosimilar Drugs Varies Significantly Across Pharmacy Benefit Managers
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
'Not just adding another drug to your pharmacy': CAR T, explained

Share This Article